Effective Utilization of Pharmacoeconomics for Decision Makers Judith D. BentkoverRon Corey Current Opinion 30 September 2012 Pages: 75 - 80
Integrating Healthcare Standards and Performance Measurement Richard G. KossLinda S. HanoldJerod M. Loeb Current Opinion 30 September 2012 Pages: 81 - 84
Clinical and Economic Implications of Non-Adherence to HAART in HIV Infection Alissa ScaleraAhmed M. BayoumiAlice Lin-in Tseng Leading Article 30 September 2012 Pages: 85 - 91
Outcomes Associated with a Disease Management Program for End-Stage Renal Disease Allen R. Nissenson Leading Article 30 September 2012 Pages: 93 - 100
Worksite Health Promotion Bruce Sherman Practical Disease Management 30 September 2012 Pages: 101 - 108
Practical Considerations for the Design and Evaluation of Disease Education and Management Programs in the Workplace Seth SerxnerDavid Anderson Review Article 30 September 2012 Pages: 109 - 115
Role of Parent Training in the Effective Management of Attention-Deficit/Hyperactivity Disorder Thomas J. PowerHeather F. RussellSuzanne M. Grim Review Article 30 September 2012 Pages: 117 - 126
The Development of a Tool to Assess Quality of Cost Estimates Philip JacobsGreg FinlaysonNadine MacLean Original Research Article 30 September 2012 Pages: 127 - 132
Spotlight on Paclitaxel in Non-Small Cell Lung Cancer Greg L. PloskerMiriam Hurst Adis Spotlight 30 September 2012 Pages: 133 - 136